Key result
Statin use shows no association with pulmonary embolism severity in cohort analysis.
Why the study?
Does statin use reduce pulmonary embolism severity in patients with confirmed PE?
Cohort
No
Does statin use reduce pulmonary embolism severity in patients with confirmed PE?
Statin use prior to a pulmonary embolism event is not associated with a reduction in the clinical severity of the PE at presentation.
Background: Recent studies have demonstrated decreased rates of venous thrombotic events, including pulmonary embolism (PE), in patients taking statins. It, however, remains elusive whether statins could also impact PE severity. Objectives: To investigate a potential association between statin use and the severity of PE in a retrospective cohort. Methods: We performed a retrospective data analysis of patients with PE confirmed by computed tomography pulmonary angiography between January 1, 2010, and December 31, 2019, at the University Hospital Graz, Austria. PE severity was assessed based on the 2019 European Society of Cardiology guidelines. Results: ), no significant differences in PE severity were found. Conclusion: Statin use was not associated with PE severity. The smaller proportion of low-risk PE in statin users is likely attributable to their older age, higher BMI, and comorbidities.
No takes yet. Share an insight, caveat, or question.
Gressenberger et al. (2025) conducted a cohort in Pulmonary embolism. Statin use vs. No statin use was evaluated on Pulmonary embolism severity. Statin use was not associated with pulmonary embolism severity, with no significant differences found between groups.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: